gADSCs were seeded and cultured in 6-well plates. When the cell confluence reached 50%, cells were treated with 0.2 mM AICAR (AMPK activator), 4.0 μM Dorsomorphin (Compound C) 2HCl (AMPK inhibitor), 0.4 mM Valproic acid (VPA) (NOTCH activator), and 1.2 μM LY411575 (NOTCH inhibitor) for 24 h. Untreated gADSCs and gADSCs treated with AICAR, Dorsomorphin (Compound C) 2HCl, Valproic acid (VPA), and LY411575 were simultaneously differentiated into adipocytes. The induction and identification were conducted using a method similar to that of the induction of gADSCs differentiation into adipocytes in this study.
Free full text: Click here